Accessibility Menu
Ambu A/s logo

Ambu A/s(OTC) AMBBY

Current Price$10.51
Market Cap$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-19%
5 Year-70%
1 Year-31%
1 Month+11%
Ambu A/s last closing stock price
MetricPriceDate
Last closeUSD 10.512026-07-20
Ambu A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.35%USD 9.702026-07-13
1 month+10.52%USD 9.512026-06-17
3 month-4.45%USD 11.002026-04-20
Year to date-20.38%USD 13.202025-12-31
1 year-31.3%USD 15.302025-07-17
3 year-31.64%USD 15.372023-07-18
5 year-69.76%USD 34.762021-07-21
Since inception-19.46%USD 13.052017-07-31

Ambu A/s Financials at a Glance

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-DKK 18.75B

Net Income (TTM)

DKK 478.62M

EPS (TTM)

$0.28

P/E Ratio

37.89

Dividend

$0.06

Beta (Volatility)

0.53 (Low)

Price

$10.51

Volume

102

Open

$10.51

Previous Close

$10.51

Daily Range

$10.51 - $10.51

52-Week Range

$8.55 - $16.78

Estimated Earnings Date

Aug 21, 2024

AMBBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ambu A/s

Ambu A/S is a leading developer and manufacturer of diagnostic and life-supporting devices for hospitals and rescue services. The company operates in three segments: Anaesthesia, Patient Monitoring & Diagnostics, and Visualisation, providing innovative solutions to enhance patient care.

Products and Services
  • Resuscitators, face masks, and laryngeal masks in the Anaesthesia segment
  • Electrodes for cardiology and neurophysiology in Patient Monitoring & Diagnostics
  • Single-use visualisation devices for bronchoscopy procedures in the Visualisation segment
Growth Outlook
  • Revenue of DKK 1.6 billion in Q2 2026, showing consistent growth
  • Operating income margin of 10.1% indicates strong operational efficiency
  • Net income of DKK 123 million in Q2 2026 reflects solid profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of DKK 6.3 billion demonstrates robust performance
  • Net profit margin of 7.8% indicates effective cost management
  • Current ratio of 2.92 suggests strong liquidity position
Ambu A/S has established itself as a key player in the medical devices industry, focusing on innovative solutions that cater to the needs of healthcare professionals. The company's diverse product offerings and commitment to quality have positioned it well for future growth. Recent financial performance highlights a strong revenue trajectory and profitability, making it an attractive option for potential investors. The solid liquidity and operational efficiency further enhance the company's appeal in the competitive healthcare sector.
AI Generated • Jul 1, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,384

CEO

Britt Meelby Jensen, MBA

Website

www.ambu.com

Headquarters

Ballerup, CR 2750, DK

AMBBY Financials

Key Financial Metrics (TTM)

Gross Margin

55.82%

Operating Margin

10.71%

Net Income Margin

7.81%

Return on Equity

7.92%

Return on Capital

11.20%

Return on Assets

6.27%

Earnings Yield

2.64%

Dividend Yield

0.61%

Payout Ratio

22.85%

Stock Overview

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

232.24M

Volume

102

Avg. Volume

206.129

Financials (TTM)

Gross Profit

-DKK 11.55B

Operating Income

DKK 656.39M

EBITDA

DKK 1.05B

Operating Cash Flow

DKK 853.48M

Capital Expenditure

-DKK 237.48M

Free Cash Flow

DKK 616.29M

Cash & ST Invst.

DKK 691.68M

Total Debt

DKK 551.54M

Ambu A/s Performance Analysis

Ambu A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30DKK 646,011,7000.2%
20232023-09-30DKK 683,534,3945.8%
20242024-09-30DKK 783,483,30914.6%
20252025-09-30DKK 893,338,34914.0%
Ambu A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-3.0%
Q42025-09-30-1653.4%
Q12025-12-31106.7%
Q22026-03-312.6%
Ambu A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30DKK 0.05-66.1%
20232023-09-30DKK 0.0973.8%
20242024-09-30DKK 0.1338.8%
20252025-09-30DKK 0.34163.5%
Ambu A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-35.2%
Q42025-09-30-6.5%
Q12025-12-312.3%
Q22026-03-314.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 1.60B

+2.9%

Gross Profit

DKK 963.75M

+2.3%

Gross Margin

60.27%

N/A

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$461.23K

N/A

Employees

5,292

N/A

Net Income

DKK 123.01M

-34.6%

EBITDA

DKK 275.50M

-14.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 691.68M

+8.1%

Total Debt

DKK 551.54M

-0.4%

Accounts Receivable

DKK 979.97M

+7.6%

Inventory

DKK 1.23B

+1.5%

Long Term Debt

DKK 466.46M

-2.4%

Short Term Debt

DKK 170.08M

+123.8%

Return on Assets

6.27%

N/A

Return on Invested Capital

9.95%

N/A

Free Cash Flow

DKK 200.37M

+150.5%

Operating Cash Flow

DKK 258.05M

+60.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMFPFAmplifon S.p.A.
$11.21+0.00%
CZMWYCarl Zeiss Meditec AG
$31.40+1.06%
CZMWFCarl Zeiss Meditec AG
$33.50+0.00%
NHNKYNihon Kohden Corporation
$9.23+0.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%
NUNu Holdings
$14.09-0.01%
CLFCleveland-Cliffs
$11.93+0.09%

Questions About AMBBY

What is the current price of Ambu A/s?

Ambu A/s is trading at $10.51 per share.

What is the 52-week range for Ambu A/s?

Over the past 52 weeks, Ambu A/s has traded between $8.55 and $16.78.

How much debt does Ambu A/s have?

As of the most recent reporting period, Ambu A/s reported total debt of DKK 84.96M.

How much cash does Ambu A/s have on hand?

Ambu A/s reported DKK 106.55M in cash and cash equivalents in its most recent financial results.

What is Ambu A/s’s dividend yield?

Ambu A/s currently has a dividend yield of 0.61%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services